Literature DB >> 2995832

DNA sequence at the end of IS1 required for transposition.

P Gamas, D Galas, M Chandler.   

Abstract

The insertion sequence IS1 belongs to a class of bacterial transposable genetic elements that can form compound transposons in which two copies of IS1 flank an otherwise non-transposable segment of DNA. IS1 differs from other known elements of this class (such as IS10, IS50 and IS903) in several respects. It is one of the smallest known insertion elements, exhibits a relatively complex array of open reading frames, is present in the chromosomes of various Enterobacteria, in some cases in many copies, and its insertion can result in the duplication of either 8 or 9 base pairs (bp) in the target DNA. Furthermore, although, like other members of the compound class, it seems to undergo direct transposition, IS1 also promotes replicon fusion (co-integrate formation) at a relatively high frequency. Like all other elements studied to date, the integrity of the extremities of IS1 are essential for efficient transposition. We have constructed a test system to determine the minimal DNA sequences at the extremities of IS1 required for transposition. Sequential deletions of the end sequences reveal that 21-25 bp of an isolated extremity are sufficient for transposition. A specific sequence 13-23 bp from the ends, defining the edge of the minimal sequence, is implicated as an essential site. The sites, symmetrically arrayed at both ends of IS1, correspond to the apparent consensus sequence of the known binding sites for the Escherichia coli DNA-binding protein (called integration host factor or IHF) which is required for the site-specific recombination that leads to integration of bacteriophage lambda into the bacterial genome. The sites at the ends of IS1 may thus bind a host protein, such as JHF or a related protein, that is involved in regulating the transposition apparatus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995832     DOI: 10.1038/317458a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

Review 1.  Insertion sequences.

Authors:  J Mahillon; M Chandler
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

2.  Frameshifting is required for production of the transposase encoded by insertion sequence 1.

Authors:  Y Sekine; E Ohtsubo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  dnaA, an essential host gene, and Tn5 transposition.

Authors:  J C Yin; W S Reznikoff
Journal:  J Bacteriol       Date:  1987-10       Impact factor: 3.490

4.  Transposition of IS91 does not generate a target duplication.

Authors:  E Diaz-Aroca; M V Mendiola; J C Zabala; F de la Cruz
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

5.  Genome of bacteriophage P1.

Authors:  Małgorzata B Łobocka; Debra J Rose; Guy Plunkett; Marek Rusin; Arkadiusz Samojedny; Hansjörg Lehnherr; Michael B Yarmolinsky; Frederick R Blattner
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

6.  Determining the DNA sequence elements required for binding integration host factor to two different target sites.

Authors:  L M Hales; R I Gumport; J F Gardner
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

7.  Replication of pSC101: effects of mutations in the E. coli DNA binding protein IHF.

Authors:  P Gamas; A C Burger; G Churchward; L Caro; D Galas; M Chandler
Journal:  Mol Gen Genet       Date:  1986-07

8.  Construction of an IS946-based composite transposon in Lactococcus lactis subsp. lactis.

Authors:  D A Romero; T R Klaenhammer
Journal:  J Bacteriol       Date:  1991-12       Impact factor: 3.490

9.  Expression of F transfer functions depends on the Escherichia coli integration host factor.

Authors:  P Gamas; L Caro; D Galas; M Chandler
Journal:  Mol Gen Genet       Date:  1987-05

10.  Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli.

Authors:  B I Eisenstein; D S Sweet; V Vaughn; D I Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.